Yoshinobu Saito Selected Research

Histiocytic Necrotizing Lymphadenitis (Kikuchi Disease)

11/2022

Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinobu Saito Research Topics

Disease

18	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2021 - 01/2007
11	Neoplasms (Cancer) 04/2022 - 09/2002
10	Pneumonia (Pneumonitis) 12/2019 - 10/2002
9	Idiopathic Pulmonary Fibrosis 11/2021 - 01/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 07/2017
8	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 10/2002
6	Lung Neoplasms (Lung Cancer) 02/2019 - 08/2014
6	Infections 05/2018 - 04/2002
5	Fever (Fevers) 11/2022 - 05/2018
5	Fibrosis (Cirrhosis) 01/2021 - 10/2002
4	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2006
4	Dyspnea (Shortness of Breath) 12/2019 - 01/2008
3	COVID-19 11/2022 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2015
3	Organizing Pneumonia 01/2022 - 01/2019
3	Drug-Related Side Effects and Adverse Reactions 08/2020 - 12/2012
3	Cough 07/2017 - 01/2007
3	Renal Cell Carcinoma (Grawitz Tumor) 07/2017 - 01/2013
3	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2013 - 01/2008
2	Adenocarcinoma of Lung 02/2021 - 01/2018
2	Hepatitis 01/2021 - 01/2016
2	Carcinogenesis 01/2021 - 08/2015
2	Hemorrhage 12/2019 - 01/2018
2	Melanoma (Melanoma, Malignant) 06/2019 - 07/2017
2	Lung Diseases (Lung Disease) 01/2019 - 01/2011
2	Fatty Liver 01/2019 - 07/2017
2	Carcinoma (Carcinomatosis) 11/2018 - 02/2011
2	Granuloma 07/2017 - 01/2013
2	Non-alcoholic Fatty Liver Disease 12/2016 - 01/2016
2	Chronic Bronchitis 10/2016 - 01/2008
2	Diffuse panbronchiolitis 10/2016 - 01/2008
1	Lymphadenopathy 11/2022
1	Histiocytic Necrotizing Lymphadenitis (Kikuchi Disease) 11/2022
1	Headache (Headaches) 01/2022
1	Diabetes Mellitus 01/2022
1	Aspergillus niger infection 01/2022
1	Pulmonary Aspergillosis 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Pleural Effusion (Pleural Effusions) 04/2021

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 02/2021 - 01/2011
7	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 01/2006
7	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2002
6	CytokinesIBA 08/2022 - 04/2002
6	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 10/2002
5	NivolumabIBA 04/2021 - 07/2017
4	pirfenidoneIBA 11/2021 - 02/2014
4	osimertinibIBA 02/2021 - 01/2018
3	Monoclonal AntibodiesIBA 04/2021 - 07/2017
3	LigandsIBA 01/2021 - 12/2016
3	pembrolizumabIBA 11/2018 - 01/2018
3	Small Interfering RNA (siRNA)IBA 07/2017 - 09/2015
3	Messenger RNA (mRNA)IBA 05/2005 - 04/2002
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2016
2	EnzymesIBA 04/2022 - 01/2018
2	nintedanibIBA 11/2021 - 06/2015
2	Tyrosine Kinase InhibitorsIBA 02/2021 - 06/2015
2	ErbB Receptors (EGF Receptor)IBA 02/2021 - 08/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2020
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2021 - 08/2015
2	LipidsIBA 01/2019 - 12/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2018 - 02/2011
2	SteroidsIBA 11/2018 - 02/2009
2	MacrolidesIBA 10/2016 - 01/2008
2	Everolimus FDA Link 05/2013 - 01/2013
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 05/2013 - 01/2008
2	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2011 - 01/2006
2	Vehicle Emissions (Emissions, Vehicle)IBA 05/2005 - 04/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2005 - 09/2002
2	InterleukinsIBA 09/2002 - 04/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002 - 04/2002
1	VaccinesIBA 11/2022
1	COVID-19 VaccinesIBA 11/2022
1	Oxygen (Dioxygen)IBA 08/2022
1	NADP (NADPH)IBA 04/2022
1	DNA Repair EnzymesIBA 04/2022
1	8-hydroxyguanineIBA 04/2022
1	remdesivirIBA 01/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022
1	Calcium OxalateIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2022
1	Muscarinic AntagonistsIBA 10/2021
1	Carbon MonoxideIBA 09/2021
1	C-Reactive ProteinIBA 04/2021
1	AfatinibIBA 02/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Extracellular Matrix ProteinsIBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021

Therapy/Procedure

19	Therapeutics 08/2022 - 01/2006
4	Drug Therapy (Chemotherapy) 01/2018 - 12/2011
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2022
2	Artificial Respiration (Mechanical Ventilation) 07/2012 - 01/2006
1	Radiotherapy 01/2022
1	Hepatectomy 01/2021